Protein detail

STAB1

Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)

Entry name
STAB1
UniProt ID
EVMP confidence score
0.28
Supporting publications (n)
1
Transmembrane count
1
Protein classification
Predicted membrane proteinsTransporters
Basic Information
Protein Names
Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)
Protein Class (2)
Predicted membrane proteinsTransporters
Protein Function
Transporters
Transmembrane
2479..2499; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (7)
CLEVER-1FEEL-1FELE-1FEX1KIAA0246SCARH2STAB-1
Gene Description
Stabilin 1
Chromosome
3
Position
52495338-52524495
Supporting publications (n)
1
EVMP confidence score
0.28
Fluorescence & Localization
STAB1 fluorescence
Tissue SpecificbrainCell SpecificEarly spermatidsSecretome LocationIntracellular and membraneSecretome FunctionReceptor
Function & Pathway
Relations & Evidence35

Ligand-Receptor Signaling (34)

34 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membraneplasma_membraneOmniPathYes
plasma_membrane_transmembraneplasma_membrane_transmembraneMembranomeYes
plasma_membrane_transmembraneplasma_membrane_transmembraneCSPAYes
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathYes
cell_surfacecell_surfaceSurfaceomeYes
cell_surfacecell_surfaceOmniPathYes
receptorreceptorCellinkerYesYes
receptorreceptorAlmen2009YesYes
receptorreceptorCellCellInteractionsYesYes
scavengerreceptorHGNCYesYes
Page 3 of 4PreviousNext

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry127863537
Sequence, Structure & Domains

Sequences

Length
2,570
Mass
275,482
Sequence
MAGPRGLLPLCLLAFCLAGFSFVRGQVLFKGCDVKTTFVTHVPCTSCAAIKKQTCPSGWLRELPDQITQDCRYEVQLGGSMVSMSGCRRKCRKQVVQKACCPGYWGSRCHECPGGAETPCNGHGTCLDGMDRNGTCVCQENFRGSACQECQDPNRFGPDCQSVCSCVHGVCNHGPRGDGSCLCFAGYTGPHCDQELPVCQELRCPQNTQCSAEAPSCRCLPGYTQQGSECRAPNPCWPSPCSLLAQCSVSPKGQAQCHCPENYHGDGMVCLPKDPCTDNLGGCPSNSTLCVYQKPGQAFCTCRPGLVSINSNASAGCFAFCSPFSCDRSATCQVTADGKTSCVCRESEVGDGRACYGHLLHEVQKATQTGRVFLQLRVAVAMMDQGCREILTTAGPFTVLVPSVSSFSSRTMNASLAQQLCRQHIIAGQHILEDTRTQQTRRWWTLAGQEITVTFNQFTKYSYKYKDQPQQTFNIYKANNIAANGVFHVVTGLRWQAPSGTPGDPKRTIGQILASTEAFSRFETILENCGLPSILDGPGPFTVFAPSNEAVDSLRDGRLIYLFTAGLSKLQELVRYHIYNHGQLTVEKLISKGRILTMANQVLAVNISEEGRILLGPEGVPLQRVDVMAANGVIHMLDGILLPPTILPILPKHCSEEQHKIVAGSCVDCQALNTSTCPPNSVKLDIFPKECVYIHDPTGLNVLKKGCASYCNQTIMEQGCCKGFFGPDCTQCPGGFSNPCYGKGNCSDGIQGNGACLCFPDYKGIACHICSNPNKHGEQCQEDCGCVHGLCDNRPGSGGVCQQGTCAPGFSGRFCNESMGDCGPTGLAQHCHLHARCVSQEGVARCRCLDGFEGDGFSCTPSNPCSHPDRGGCSENAECVPGSLGTHHCTCHKGWSGDGRVCVAIDECELDMRGGCHTDALCSYVGPGQSRCTCKLGFAGDGYQCSPIDPCRAGNGGCHGLATCRAVGGGQRVCTCPPGFGGDGFSCYGDIFRELEANAHFSIFYQWLKSAGITLPADRRVTALVPSEAAVRQLSPEDRAFWLQPRTLPNLVRAHFLQGALFEEELARLGGQEVATLNPTTRWEIRNISGRVWVQNASVDVADLLATNGVLHILSQVLLPPRGDVPGGQGLLQQLDLVPAFSLFRELLQHHGLVPQIEAATAYTIFVPTNRSLEAQGNSSHLDADTVRHHVVLGEALSMETLRKGGHRNSLLGPAHWIVFYNHSGQPEVNHVPLEGPMLEAPGRSLIGLSGVLTVGSSRCLHSHAEALREKCVNCTRRFRCTQGFQLQDTPRKSCVYRSGFSFSRGCSYTCAKKIQVPDCCPGFFGTLCEPCPGGLGGVCSGHGQCQDRFLGSGECHCHEGFHGTACEVCELGRYGPNCTGVCDCAHGLCQEGLQGDGSCVCNVGWQGLRCDQKITSPQCPRKCDPNANCVQDSAGASTCACAAGYSGNGIFCSEVDPCAHGHGGCSPHANCTKVAPGQRTCTCQDGYMGDGELCQEINSCLIHHGGCHIHAECIPTGPQQVSCSCREGYSGDGIRTCELLDPCSKNNGGCSPYATCKSTGDGQRTCTCDTAHTVGDGLTCRARVGLELLRDKHASFFSLRLLEYKELKGDGPFTIFVPHADLMSNLSQDELARIRAHRQLVFRYHVVGCRRLRSEDLLEQGYATALSGHPLRFSEREGSIYLNDFARVVSSDHEAVNGILHFIDRVLLPPEALHWEPDDAPIPRRNVTAAAQGFGYKIFSGLLKVAGLLPLLREASHRPFTMLWPTDAAFRALPPDRQAWLYHEDHRDKLAAILRGHMIRNVEALASDLPNLGPLRTMHGTPISFSCSRTRAGELMVGEDDARIVQRHLPFEGGLAYGIDQLLEPPGLGARCDHFETRPLRLNTCSICGLEPPCPEGSQEQGSPEACWRFYPKFWTSPPLHSLGLRSVWVHPSLWGRPQGLGRGCHRNCVTTTWKPSCCPGHYGSECQACPGGPSSPCSDRGVCMDGMSGSGQCLCRSGFAGTACELCAPGAFGPHCQACRCTVHGRCDEGLGGSGSCFCDEGWTGPRCEVQLELQPVCTPPCAPEAVCRAGNSCECSLGYEGDGRVCTVADLCQDGHGGCSEHANCSQVGTMVTCTCLPDYEGDGWSCRARNPCTDGHRGGCSEHANCLSTGLNTRRCECHAGYVGDGLQCLEESEPPVDRCLGQPPPCHSDAMCTDLHFQEKRAGVFHLQATSGPYGLNFSEAEAACEAQGAVLASFPQLSAAQQLGFHLCLMGWLANGSTAHPVVFPVADCGNGRVGIVSLGARKNLSERWDAYCFRVQDVACRCRNGFVGDGISTCNGKLLDVLAATANFSTFYGMLLGYANATQRGLDFLDFLDDELTYKTLFVPVNEGFVDNMTLSGPDLELHASNATLLSANASQGKLLPAHSGLSLIISDAGPDNSSWAPVAPGTVVVSRIIVWDIMAFNGIIHALASPLLAPPQPQAVLAPEAPPVAAGVGAVLAAGALLGLVAGALYLRARGKPMGFGFSAFQAEDDADDDFSPWQEGTNPTLVSVPNPVFGSDTFCEPFDDSLLEEDFPDTQRILTVK
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q9NY15-1; Sequence=Displayed; Name=2; IsoId=Q9NY15-2; Sequence=VSP_050764, VSP_050765
Alternative Sequence
746..803; CSDGIQGNGACLCFPDYKGIACHICSNPNKHGEQCQEDCGCVHGLCDNRPGSGGVCQQ -> VSPILSWGEVWGTQGLLHRLASDWLCVWAKPATLALGFSYLCSGKLDQIISHILIKNN (in isoform 2); 804..2570; Missing (in isoform 2)

Domain & Motif Annotations

Domain (FT)
110..148; EGF-like 1; 156..193; EGF-like 2; 195..229; EGF-like 3; 232..271; EGF-like 4; 356..494; FAS1 1; 506..641; FAS1 2; 728..768; EGF-like 5; 818..858; EGF-like 6; 861..903; EGF-like 7; 904..946; EGF-like 8; 947..986; EGF-like 9; 988..1118; FAS1 3; 1128..1253; FAS1 4; 1327..1392; Laminin EGF-like 1; 1416..1454; EGF-like 10; 1455..1496; EGF-like 11; 1497..1539; EGF-like 12; 1540..1582; EGF-like 13; 1582..1708; FAS1 5; 1724..1864; FAS1 6; 1966..2031; Laminin EGF-like 2; 2056..2090; EGF-like 14; 2091..2131; EGF-like 15; 2132..2174; EGF-like 16; 2206..2301; Link; 2322..2459; FAS1 7
Clinical Relevance
Disease Involvement
Disease variant
Antibody
Supporting Publications1
PMIDTitleRelated sentences
39778061Proteomic Analysis of Plasma Exosomes Enables the Identification of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease.No related sentences available